4BIO Capital appoints Brian P. McVeigh as Venture Partner
July 01, 2020 02:00 ET
|
4Bio Capital
Press Release 4BIO Capital appoints Brian P. McVeigh as Venture Partner Appointment of seasoned pharma and biotech industry veteran to strengthen 4BIO Capital’s US operations 1 July 2020 LONDON...
4BIO Capital announces strategic investment from Japanese pharmaceutical company Kyowa Kirin
June 08, 2020 07:00 ET
|
4Bio Capital
Press Release 4BIO Capital announces strategic investment from Japanese pharmaceutical company Kyowa Kirin Kyowa Kirin’s first strategic investment into a Venture Capital fund Kyowa Kirin to...
4BIO Capital announces strategic investment from Japanese pharmaceutical company Kyowa Kirin
June 08, 2020 02:00 ET
|
4Bio Capital
Press Release 4BIO Capital announces strategic investment from Japanese pharmaceutical company Kyowa Kirin Kyowa Kirin’s first strategic investment into a Venture Capital fund Kyowa Kirin to...
4BIO Capital portfolio company ADC Therapeutics SA closes an upsized IPO of over $267.6 million
May 20, 2020 07:00 ET
|
4Bio Capital
Press Release 4BIO Capital portfolio company ADC Therapeutics SA closes an upsized IPO of over $267.6 million 20 May 2020 LONDON & BOSTON – 4BIO Capital (“4BIO” or “the...
4BIO Capital leads Redpin Therapeutics’ $15.5 million Series A
March 25, 2020 07:03 ET
|
4Bio Capital
Press Release 4BIO Capital leads Redpin Therapeutics’ $15.5 million Series A Pioneering chemogenetics company is one of the first investments from 4BIO Capital’s Ventures II fund 25 March 2020 ...
4BIO Capital raises $50 million in first close of new advanced therapies fund
September 09, 2019 07:00 ET
|
4Bio Capital
Press Release 4BIO Capital raises $50 million in first close of new advanced therapies fund 4BIO Ventures II fund solely focused on advanced therapies targeting $150 million final...
4BIO Capital raises $50 million in first close of new advanced therapies fund
September 09, 2019 02:00 ET
|
4Bio Capital
Press Release 4BIO Capital raises $50 million in first close of new advanced therapies fund 4BIO Ventures II fund solely focused on advanced therapies targeting $150 million final...